Kane Biotech

Canada
Victoriaville, Quebec, Canada, R3T 6C6

Company profile

Kane Biotech company profile

Kane Biotech Inc., a biotechnology company, engages in the research and development of products to prevent and disperse biofilms in medical and industrial applications. Its products include ALEDEX, an antimicrobial/antibiofilm composition comprising protamine sulfate and chlorhexidine, with applications in anti-infective medical device coatings, animal care and dairy, and food processing industries; DispersinB, an antibiofilm enzyme that inhibits, as well as disperses microbial biofilms, with applications in wound care, medical devices, oral care, and animal healthcare; and a toothpaste and mouthwash additive based on competence stimulating peptide technology for preventing and dispersing dental plaque biofilms. The company was founded in 2001 and is headquartered in Winnipeg, Canada.

Business identity

Contact email
[email protected]
Phone number
+1 2044531314
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2001-01-01, Year

Headquarters

Postal code
R3T 6C6
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
28
Total equity funding
$21.9M
Last funding
Post IPO Debt / $733,011 / 2025-06-26
Last equity funding
Post IPO Equity
Investors
7
Lead investors
4
Articles
122
Exited on
2003-05-16

Founders and investors

Lead investors

ManitobaNational Research Council of Canada Industrial Research Assistance ProgramU.S. Department of DefenseWestern Economic Diversification Canada

Investors

Government of CanadaManitobaNational Research Council of Canada Industrial Research Assistance ProgramU.S. Department of DefenseWestern Economic Diversification Canada